ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS

Clinical trials for ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS trials appear

Sign up with your email to follow new studies for ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested to boost cancer immunotherapy

Disease control Recruiting now

This study is testing a new oral medication called Alintegimod, given alongside the immunotherapy drugs ipilimumab and nivolumab. It aims to see if this combination is safe and can help control advanced cancers that have spread or returned after other treatments. The study will e…

Matched conditions: ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS

Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS

Get alerted when new ANAPLASTIC LYMPHOMA KINASE GENOMIC TUMOR ABERRATIONS trials appear

New pill tested to boost cancer immunotherapy